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Abstract
There is increasing evidence suggesting a wider biological role of erythropoietin (Epo) and Epo receptor (EpoR)
not related to erythropoiesis, such as the detection of EpoR in other cells, i.e. polymorphonuclear leukocytes,
megakaryocytes, endothelial, myocardial and neural cells. In this study, by using a mouse model (designated
tg6) that constitutively overexpresses human Epo in an oxygen-independent manner, we have investigated mast
cell and macrophage number and distribution in duodenal mucosa using immunohistochemical, morphometric
and image analysis methods. The results showed that tryptase-positive mast cells and BM8-positive macrophages
were more numerous in duodenal mucosa specimens of tg6 mice compared with wild-type mice. Moreover,
whereas in wild-type specimens both mast cells and macrophages were generally scattered throughout the
villus, in tg6 specimens they were aligned along the axis of the villus. Morphometric analysis conﬁrms this
observation, and the quantitative analysis of the spatial distribution of the cells in duodenal villi indicated that
in both wild-type and tg6 groups the macrophage and mast cell distribution was characterized by signiﬁcant
deviations from randomness. In addition, an increased number of c-kit-positive cells have been identiﬁed in the
villus axis of tg6 mice, indicating an expanded compartment of mast cell precursors in the intestinal mucosa of
these animals. Finally, we have also demonstrated that in tg6 specimens the number of duodenal epithelial cells
positive for Epo were signiﬁcantly higher as compared to wild type. Overall, these data conﬁrm that Epo, acting
as a general stimulator of the hemopoietic compartment, is able to induce an expansion of two effectors of
the immune response, mast cells and macrophages, in a speciﬁc peripheral site, the duodenal mucosa, in the
tg6 mouse experimental model.
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Introduction
Erythropoietin (Epo) is a low-molecular weight glycoprotein
hormone stimulator of erythropoiesis produced in the fetal
liver and subsequently in the adult kidney (Tilbrook & Klin-
ken, 1999). Epo exerts its action through its speciﬁc receptor
(EpoR), a member of the cytokine receptor superfamily,
which is mainly expressed on the erythroid colony-forming
unit (Tilbrook & Klinken, 1999). The importance of the
Epo-EpoR system in primary and deﬁnitive erythropoiesis
has been determined by generating lines of mutant mice
lacking either the Epo or the EpoR gene (Wu et al. 1995; Lin
et al. 1996).
There is increasing evidence suggesting a wider biological
role of Epo-EpoR not related to erythropoiesis, such as the
detection of EpoR in other cells, i.e. polymorphonuclear leu-
kocytes, megakaryocytes, endothelial, myocardial and neu-
ral cells (Buemi et al. 2003; Fraser et al. 1989; Sela et al.
2001; Anagnostou et al. 1994; Ribatti et al. 1999).
A mouse model (designated tg6) that constitutively over-
expresses human Epo in an oxygen-independent manner
has been generated (Ruschitzka et al. 2000; Wagner et al.
2001; Vogel et al. 2003). Transgenic mice show a 10- to
12-fold elevation of Epo plasma levels leading to hematocrit
values of up to 0.9. Considering that excessive erythrocytosis
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has been observed in various human diseases, such as poly-
cythemia vera, by using this experimental model it has been
possible to investigate the effect of an increase in red blood
cell number on various organs. Ogunshola et al. (2005)
demonstrated that brain vessel density of tg6 mice was sig-
niﬁcantly reduced and vessel diameter signiﬁcantly
increased compared with wild-type mice. Moreover, tg6
brain vascular endothelial cells appeared to be activated,
with increased luminal protrusions. Heinicke et al. (2006)
demonstrated degenerative processes in the liver and kid-
ney of tg6 mice, characterized by increased vascular perme-
ability, chronic progressive inﬂammation (characterized by
lymphoid cell inﬁltrations) and hemosiderin deposition.
Moreover, most of the tg6 mice showed severe ﬁber degen-
eration of the sciatic nerve, decreased number of neuro-
muscular junctions, and degeneration of skeletal muscle
ﬁbers.
More recently, by using the same experimental model,
Katz et al. (2007) demonstrated that Epo affects both T
and B populations, and augments B-cell responses, mani-
fested in endogenous normal polyclonal immunoglobulin
production, lipopolysaccharide (LPS)-induced proliferation
of splenocytes, as well as speciﬁc antibody response to
antigen stimulation.
In this study, using the tg6 model, we have investigated
the impact of excessive Epo production on mast cells and
macrophages in duodenal mucosa. For this purpose we
have studied the immunohistochemical expression of tryp-
tase, a speciﬁc mast cell marker, BM8, a speciﬁc macro-
phage marker, c-kit, an indicator of mast cells and mast cell
precursors, and Epo-EpoR in duodenal mucosa of tg6 and
wild-type mice. Furthermore, we have analyzed their spatial
distribution utilizing an image analysis system and a mathe-
matical model as a quantitative approach.
Materials and methods
Mice
The tg mice were generated by pronuclear microinjection of the
full-length human Epo cDNA driven by the human platelet-
derived growth factor (PDFG) B-chain promoter as previously
described (Ruschitzka et al. 2000). The resulting tg mouse line
TgN (PDGFBEPO) 321ZbZ (termed tg6) showed increased Epo
levels in plasma and brain (Wiessner et al. 2001) and was bred
by mating hemizygous males to wild-type C57BL ⁄ 6 females. Half
of the offspring were hemizygous for the transgene (n = 15),
and the other half were wild-type (n = 15) and served as con-
trols. Male and female mice were used at 4–5 months of age.
Immunohistochemistry
After ﬁxation in 10% (w ⁄ v) phosphate-buffered formaldehyde
solution, the tissues were processed, trimmed, embedded in par-
afﬁn wax, sectioned at 4 lm thickness. Two murine monoclonal
antibodies (MAb) against the mast cell marker tryptase (MAb
AA1, Dako, Glostrup, Denmark) and the pan-macrophage
marker BM8 (Bachem Biosciences King of Prussia, PA, USA; Ma-
lorny et al. 1986), and three rabbit polyclonal antibodies against
CD117 ⁄ c-kit (Dako), Epo and EpoR (sc-73963 and sc-5624, Santa
Cruz Biotechnology, Santa Cruz, CA, USA) and were used. In
brief, sections were collected on 3-amino-propyl-triethoxysilane-
coated slides, deparafﬁnized by the xylene-ethanol sequence,
rehydrated in a graded ethanol scale and in Tris-buffered saline
(TBS, pH 7.6), and incubated overnight at 4 C with the MAbs
(diluted 1 : 100 in TBS) and the polyclonal antibodies (diluted
1 : 200 in TBS) after prior antigen retrieval by enzymatic diges-
tion with Ficin (Sigma, St. Louis, MO, USA) for 30 min at room
temperature. The immunoreaction was performed with alkaline
phosphatase anti-alkaline phosphatase (APAAP; Dako) and Fast
Red as chromogen, followed by hematoxylin counterstaining.
Tissue sections processed in the absence of primary or secondary
antibody, or with a blocking antibody (Dako) displayed no
appreciable nonspeciﬁc stain.
Cell counts
Tryptase-positive mast cells, BM8-positive macrophages, c-kit-,
Epo- and EpoR-positive cells counts were carried out in well-
orientated sections cut perpendicularly to the mucosa. The
counts were performed on a Zeiss Axioskop light microscope
(Carl Zeiss Italy, Arese, Italy), using a micrometer grid ﬁtted in
a ·10 eyepiece at ·100 objective magniﬁcation. In all, 15–25
contiguous, nonoverlapping rectangular areas (each area mea-
sured 0.0117 mm2) of three sections per sample for wild-type
and tg6 specimens, were examined. Mean, median and stan-
dard deviation were determined for each group of samples.
Image analysis methods
Computer-assisted image analysis was performed to characterize
the spatial distribution of the cells in the villi of the duodenum,
starting from 30 images obtained from 10 wild-type and 10 tg6
specimens of these structures taken at a primary magniﬁcation
of ·200. Images were analyzed according to a previously
detailed procedure (see Guidolin et al. 2006). In brief, the study
area within each image was deﬁned as the area corresponding
to the villus proﬁle and the central axis of the villus was interac-
tively traced. To discriminate the cells, a colour thresholding
procedure was applied, followed by further processing steps to
remove artefacts and provide a deagglomeration of the cell pro-
ﬁles. The distance of each proﬁle from the central axis of the
villus was then estimated.
In the same study area, 100 random (Poisson) point patterns
were ﬁnally computer generated. Each pattern had a number
of points equal to the number of observed cell proﬁles. They
provided Monte Carlo estimates (Besag & Diggle, 1997) of the
distances from the central axis in the case of a random spatial
distribution of the cells in the villus.
To characterize the relationship between the cells and the
central axis of the villus an approach based on ‘spatial statis-
tics’ (Diggle, 1983) was used. It involves the calculation of the
cumulative frequency distribution [G(d)] of all the observed
cell-to-axis distances. To interpret spatial relationship of the
cells to the central axis statistically, G(d) has to be compared
with the value [G0(d)] estimated on the random (Poisson) point
patterns (Ripley, 1979). If G(d) is signiﬁcantly greater than
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G0(d) for any range of d, then the cells are closer to the center
of the villus than expected by chance. Conversely, if G(d) is
signiﬁcantly lower than G0(d), then short cell-to-central axis
distances are less frequent than expected by chance, i.e. the
cells tend to place themselves at the periphery of the villus
(Philimonenko et al. 2000).
Statistics
The signiﬁcance of differences in cell counts between tg6 mice
and their wild-type littermates was assessed using PRISM software.
Values are means ± SD. Statistical signiﬁcance (P < 0.05%) was
calculated using an unpaired t-test of independent samples. The
public domain statistical software R 2.6.0 (R Development Core
Team, 2005) was used to obtain estimators of G(d) and G0(d)
(together with the 95% conﬁdence limits) from the observed
and simulated cell-to-central axis distances, respectively.
Results
As shown in Fig. 1, tryptase-positive mast cells and, respec-
tively, BM8-positive macrophages were more numerous in
duodenal mucosa specimens of tg6 mice compared with
wild-type mice. Whereas in wild-type specimens both mast
cells and macrophages were generally scattered throughout
the villus, in tg6 specimens they were aligned along the axis
of the villus.
Moreover, the density of c-kit-positive mast cell precur-
sors in the lamina propria of Epo-overexpressing tg6 mice is
higher than in wild-type mice; as well, the Epo-positive
epithelial and stromal cells and EpoR-positive stromal cells
were more numerous in tg6 as compared to wild-type
specimens (Fig. 2). Morphometric analysis conﬁrmed these
ﬁndings (Table 1). There were signiﬁcant differences
(P < 0.001) in all counts between the two groups.
The quantitative analysis of the spatial distribution of
the cells in duodenal villi indicated that in both wild-type
and tg6 groups the macrophage and mast cell distribu-
tion was characterized by signiﬁcant deviations from ran-
domness. In particular, the cell patterns were in both
cases preferentially clumped around the central axis of
the villus, as indicated by a G(d) signiﬁcantly higher than
expected under complete spatial randomness, expression
of a trend towards clustering (Fig. 3A). However, when
compared to the samples from wild-type mice, macro-
phages from tg6 mice were signiﬁcantly (P < 0.05) closer
to the central axis of the villi, as indicated by their lower
mean cell-to-axis distance (Fig. 3B).
Discussion
In this study we have demonstrated that in the duodenal
mucosa of Epo-overexpressing tg6 mice, mast cells and mac-
rophages are more numerous as compared with wild-type
mice. Mast cells and macrophages are inﬂammatory cells
which exert fundamental functions in the physiopathology
of the intestinal mucosa. Mast cells are primarily located in
the lamina propria, where under normal conditions they
A
B
C
D
Fig. 1 Histochemical pictures of tryptase-
positive mast cells (A,B), BM8-positive
macrophages (C,D) in duodenum of wild-type
(A, C) and tg6 (B, D) mice. Note a higher
number of mast cells in tg6 specimens.
Original magniﬁcation: A–D, ·200.
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account for 2–3% of cells (Bischoff et al. 1996). Macrophag-
es are present in the small intestine in a subepithelial posi-
tion, where they can interact directly with bacteria in the
lumen and detect any microbes or microbial products that
may cross the epithelial monolayer (Platt & Mowat, 2008).
Thus, both mast cells and macrophages play a crucial role in
the processes of local defence as well as tissue homeostasis
and remodelling.
The increased density of mast cells and macrophages in
the villous lamina propria of Epo-overexpressing tg6 mice is
an intriguing ﬁnding. The unique condition we have docu-
mented here is probably due to an increase in mast cell and
macrophage production. This is certainly true for mast cells.
In fact, it emerges from our study that the density of c-kit-
positive mast cell precursors in the lamina propria of Epo-
overexpressing tg6 mice is higher than in wild-type mice
(60 ± 12 vs. 12 ± 3 cells per unit area, P < 0.001) Remark-
ably, the number of c-kit-positive cells in the lamina propria
of Epo-overexpressing tg6 mice is higher than the number
of tryptase-positive mast cells in the same transgenic
A B
C D
E F
Fig. 2 Histochemical pictures of c-kit-positive
cells in duodenum of wild-type (A) and tg6
(B) mice; Epo-positive epithelial and stromal
cells (C,D) and EpoR-positive stromal cells (E,F)
in duodenum of wild-type (C,E) and tg6 (D,F)
mice. Note a higher number of c-kit-positive
cells and an higher number of Epo- and
EpoR-positive cells in tg6 specimens. Original
magniﬁcation: A,B, ·200; C–F, ·160.
Table 1 Cell counts in the duodenum of wild-type and tg6 mice
Wild type
(n = 15)
tg6
(n = 15)
Mast cells 6 ± 2* 44 ± 7**
C-kit positive cells 12 ± 3 60 ± 12**
Macrophages 12 ± 5 36 ± 6**
Epithelial cells positive for Epo 8 ± 4 32 ± 7**
Stromal cells positive for Epo 4 ± 1 14 ± 3**
Stromal cells positive for EpoR 7 ± 2 40 ± 8**
*The values are expressed per unit area (0.0117 mm2).
**P < 0.001 vs. wild type.
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animals, indicating that the increased production of Epo
causes an expansion of the compartment of mast cell pre-
cursors in the intestinal lamina propria (60 ± 12 vs. 44 ± 7,
P < 0.001). These data are in keeping with literature data,
which indicate a proliferative expansion and an increased
activity of different cell lineages upon Epo stimulation. In
fact, it has been demonstrated previously in both Epo-trea-
ted wild-type and tg6 mice that Epo induces a higher level
of splenocyte proliferative response induced by LPS (Katz
et al. 2007). Moreover, these mice had increased production
of anti-dinitrophenyl (DNP) antibodies following immuniza-
tion with DNP-keyhole limpet hemocyanin. Finally, Epo-
treated mice showed an enhanced immune response to
clinically relevant hepatitis B surface antigen. More recently,
in vivo experiments in Epo-injected mice and in tg6 mice
showed an increased splenic dendritic cell population with
a higher cell surface expression of CD80 and CD86 (Lifshitz
et al. 2009). Overall, these data suggest a potential use of
Epo as an immunomodulator. Bogdanova et al. (2007)
demonstrated that compared with wild-type animals, the
erythrocyte lifespan is 70% shorter in tg6 mice. Transgenic
mice have a younger erythrocyte population which harbors
characteristics of accelerated aging. Moreover, in vitro
experiments showed that tg6 macrophages are more active
than wild-type macrophages and that tg6 erythrocytes are
more attractive for macrophages than wild-type ones.
Accelerated erythrocyte aging together with an increased
number and activity of macrophages resulted in an
enhanced erythrocyte clearance. As a consequence of an
enhanced elimination of older erythrocytes, whole blood
viscosity decreases. Interestingly, several features of tg6
mice, including excessive erythrocytosis and splenomegaly,
resemble the symptoms observed in patients suffering from
polycythemia vera, in which erythrocytosis is responsible for
severe thrombotic events that eventually lead to death
(Spivak, 2002).
Both mast cells and macrophages originate from bone
marrow precursors, circulate in the bloodstream as distinct
elements and reach their complete differentiation once
they have entered peripheral homing tissues. Remarkably,
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Fig. 3 Morphometric evaluation of the spatial
distribution of macrophages and mast cells in
the central axis of duodenal villus. (A)
Representative results of the analysis based
on spatial statistics. In each plot the
difference G(d)–Go(d) is drawn, together with
the 95% conﬁdence limits around the value 0
for such a difference. The spatial relationship
between cells and the central axis of the villus
has been reported. Solid lines indicate the
difference between the observed distribution
of cell-to-axis distances [G(d)] and the
estimated distribution [Go(d)] under the
hypothesis of complete spatial randomness
(CSR). Dotted lines indicate the 95%
conﬁdence envelope for CSR. In both groups
both cell types are localized around the
central axis of the villi, as indicated by a
frequency of short distances signiﬁcantly
higher than expected by chance. (B) Mean
distances between cells and the central axis
of the villi. When compared to the samples
from wild-type mice, macrophages from tg6
mice are signiﬁcantly (P < 0.05) closer to the
central axis of the villi, as indicated by their
lower mean cell-to-axis distance. Error bars
are SD. *P < 0.05 (two-sample Student’s
t-test).
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mast cells are the only bone marrow-derived cells that
maintain the stem cell factor (SCF) receptor c-kit when com-
pletely differentiated. SCF represents the main survival and
developmental factor for mast cells (Broudy, 1997). Lack of
expression of a functional c-kit receptor, as occurs in geneti-
cally mast cell-deﬁcient WBB6F1-c-kitW-c-kitW-v mice (W ⁄Wv
mice), results in a virtual absence of tissue mast cells (Kitam-
ura et al. 1978). Of note, the Vickid mouse mutant that,
because of the lack of c-kit, exhibits hematopoietic defects
causing perinatal death, could be rescued by breeding with
the Epo-overexpressing tg6 mice (Waskow & Rodewald,
2002). Indeed, introduction of an Epo transgene into a c-
kitW ⁄W background yielded Epo-transgenic c-kitW ⁄W mice,
about half of which survived long term (Waskow et al.
2002). These mutant mice, termed WEPO, demonstrate that
Epo receptor signals can partially by-pass the strict require-
ment for c-kit signalling in erythropoiesis in the absence of
c-kit in vivo (Waskow et al. 2004). Interestingly, former
investigations demonstrated that Epo down-regulates levels
of c-kit mRNA expressed by mast cells and stem cell progeni-
tors (Welham & Schrader, 1991).
These data are relevant in the light of our ﬁndings that
display a signiﬁcant increase of mast cell density in the villus
axis of Epo-overexpressing tg6 mice. This result suggests
that, under certain conditions, Epo signalling may play a
role in the development of mast cell lineage as well. We do
not know, at present, what these conditions are. Some local
factors, however, are likely to intervene, because the expan-
sion of mast cell population was not generalized but was
limited to the mucosa of the small intestine. As previously
stated, in the present study we have found an increased
population of c-kit-positive mast cell precursors localized in
the villus lamina propria of Epo-overexpressing tg6 mice.
This suggests that the increased levels of intestinal mast
cells observed in these animals are the result of an over-
production of these cells. Remarkably, we did not ﬁnd
speciﬁc signs of inﬂammation in the duodenum of Epo-
overexpressing tg6mice. In particular, no distinct neutrophil,
eosinophil or lymphocyte inﬁltration of the villus lamina
propria and epithelium could be identiﬁed. This would
exclude any signiﬁcant allergic response or local inﬂamma-
tion as the causative agent of the increased density of mast
cells and macrophages observed in tg6 transgenic mice.
In the past, Isogai et al. (2006) demonstrated that dermal
mast cells express EpoR, by double staining with anti-EpoR
antibody and anti-tryptase antibody. In addition, immuno-
reactivity for EpoR has been demonstrated in the wide-
spread population of tissue macrophages in the developing
human fetus (Juul et al. 1998). These ﬁndings have been
questioned by Elliott et al. (1996), who claimed that the
C-20 (sc 695) anti-EpoR antibody used in these studies is a
nonselective marker because it gives a false–positive signal
in the absence of EpoR. In our present study, we have used
a different antibody against EpoR and, alongside this, we
have immunostained our samples with an anti-Epo antibody
for Epo detection. Our data indicate a signiﬁcant increase of
EpoR positivity in the stromal cells of the villus axis in Epo-
overexpressing tg6 mice (40 ± 8 vs. 7 ± 2 cells per unit area,
P < 0.001). Most remarkably, the increased levels of EpoR
are accompanied by a parallel expansion of the population
of Epo-positive stromal cells localized in the villus axis in the
same animals (14 ± 3 vs. 4 ± 1 cells per unit area, P < 0.001).
In addition, we have found increased values of Epo positiv-
ity in the villus-lining epithelial cell population of tg6 trans-
genic mice (32 ± 7 vs. 8 ± 4 cells per unit area, P < 0.001).
These data suggest that an expanded population of stromal
cells in the villus axis expresses the EpoR in tg6 mice and that
stromal cells in the same anatomical site contain higher lev-
els of Epo in their cytoplasm. Given the high density of both
mast cells and macrophages in the villus lamina propria of
Tg6 mice, we cautiously conclude that a percentage of Epo-
positive and EpoR-positive stromal cells are realistic candi-
dates to represent both cell types. Interestingly, former
immunohistochemical studies for Epo detection in capillary
hemangioblastomas have demonstrated positive staining
for mast cells (Kamitani et al. 1987; Tachibana et al. 1991).
It should also be emphasized that Epo has an intrinsic
anti-apoptotic activity. For instance, it has recently been
reported that Epo protects cardiomyocytes from ischemic
injury (Hirose et al. 2007) and has a trophic effect on neu-
rons under ischemic and degenerative conditions (Sakanaka
et al. 1998). EpoR have been identiﬁed in various brain
regions, both on capillary endothelial cells as well as neuro-
nal cells (Digicalylioglu et al. 1995). Under hypoxic condi-
tions, EpoR is synthesized in astrocytes and neurons
(Bernaudin et al. 2000). Thus, we speculate that the
increased amount of mast cells and macrophages in the vil-
lus lamina propria may in part depend upon the pro-surviv-
ing function linked to Epo overexpression.
In conclusion, these data conﬁrm that Epo, acting as a
general stimulator of the hemopoietic compartment, is able
to induce an expansion of two effectors of the immune
response, such as mast cells and macrophages, in speciﬁc
peripheral sites, such as duodenal mucosa, as occurs in the
tg6 mouse experimental model.
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